Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Regencell Bioscience Holdings Limited (RGC) had Return on Investments of -53.09% for the most recently reported fiscal year, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
$-4.30M |
|
-- |
|
-- |
|
$4.74M |
|
$-4.74M |
|
$0.37M |
|
$-4.36M |
|
$-4.36M |
|
$-4.36M |
|
$-4.36M |
|
$-4.36M |
|
$-4.36M |
|
$-4.74M |
|
$-4.43M |
|
13.01M |
|
13.01M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$8.11M |
|
$0.14M |
|
$0.32M |
|
$8.44M |
|
$0.19M |
|
-- |
|
$0.03M |
|
$0.22M |
|
$8.22M |
|
$8.22M |
|
$8.22M |
|
13.01M |
|
| Cash Flow Statement Financials | |
$-4.00M |
|
$5.24M |
|
$0.10M |
|
$1.56M |
|
$2.96M |
|
$1.40M |
|
$0.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
41.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-53.09% |
|
-53.09% |
|
-51.71% |
|
|
Return on Investments |
-53.09% |
$0.63 |
|
$-0.31 |
|
$-0.31 |
|